Anti-SARS-CoV-2 hyperimmune plasma workflow

Coronavirus disease 2019 (COVID-19) caused by the novel coronavirus has become a Public Health Emergency of International Concern. Among the various treatment proposals for COVID-19 infection, passive immunotherapy using plasma from recovering patients - "convalescent plasma" (CP)- could b...

Descripción completa

Detalles Bibliográficos
Autores principales: Annamaria, Petrungaro, Eugenia, Quartarone, Paolo, Sciarrone
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283061/
https://www.ncbi.nlm.nih.gov/pubmed/32540345
http://dx.doi.org/10.1016/j.transci.2020.102850

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283061/
https://www.ncbi.nlm.nih.gov/pubmed/32540345
http://dx.doi.org/10.1016/j.transci.2020.102850

Ejemplares similares